Horace Mann (HMN) Q4 2025 earnings review
Record Year Masks Fourth Quarter Cool-Down
Horace Mann delivered on its promise of a record year, posting FY25 Core EPS of $4.71 (+39% YoY), slightly beating the high end of its $4.50-$4.70 guidance. The P&C profitability turnaround is the headline victory, with the full-year combined ratio improving over 8 points to 89.7%. However, Q4 2025 revealed cracks in the momentum: while revenue grew 6%, Core Earnings plummeted 28% YoY to $1.21/share, hindered by net investment losses and tough comparisons against a benign prior-year quarter.
🐂 Bull Case
The turnaround is real and verified. The full-year P&C combined ratio improved to 89.7% (from ~98% in FY24), driving the company to a double-digit ROE (12.4%).
Revenue grew ~7% for both the quarter and the full year. This indicates that rate actions and cross-selling initiatives are sticking without causing a mass exodus of policyholders.
🐻 Bear Case
Despite revenue growth, Q4 Core Earnings fell 28% YoY. Operating leverage went the wrong way in the quarter, potentially signaling that the 'easy comps' from the turnaround phase are over.
The company reported net investment losses (after tax) of $5.6M in Q4, continuing a trend of portfolio pressure that creates noise in the bottom line.
⚖️ Verdict: 🟢
Bullish. While the Q4 YoY profit drop is a watch item, the broader narrative holds: HMN successfully executed its multi-year P&C fix, achieving record annual earnings and a 12.4% ROE. The fundamental earnings engine is repaired.
Key Themes
P&C Segment Transformation
The primary engine for FY25's success was the Property & Casualty segment. Through aggressive rate actions and underwriting discipline, the full-year combined ratio improved by over 800 basis points to 89.7%. This successfully moves the segment from 'recovery mode' to a stable profit generator.
Q4 Margin Compression
Reversing. A concerning divergence appeared in Q4: Revenue rose 6.3%, but Net Income fell 5.2% and Core Earnings fell 28%. This suggests rising costs or unfavorable claim frequency in Q4 compared to the 'unusually benign' weather noted in the prior year's period.
Capital Build & ROE Expansion
Accelerating. The company is generating significant capital. Book value per share rose 16% to $36.47, and Adjusted Book Value hit $40.21. Core ROE expanded 300 basis points to 12.4%, comfortably meeting the 'double-digit' target set by management earlier in the year.
Sales & Distribution Momentum
Stable. Net premiums and contract charges earned rose over 7% for the year. Management cites 'sustained growth momentum' across segments, supported by expanded distribution and digital capabilities (e.g., website visits up 120% in Q3). The pivot from 'fix' to 'grow' is gaining traction.
Investment Portfolio Volatility
Net investment losses persisted, with a $5.6M after-tax loss in Q4 and $10.2M for the full year. While higher yields are helping interest income, fair value adjustments or realized losses on the portfolio continue to be a headwind to GAAP net income.
Other KPIs
Accelerating. Beat the guidance range of $4.50-$4.70 provided in Q3. This represents a 39% increase over FY24 ($3.40), confirming the successful execution of the profitability restoration plan.
Accelerating. Up 15.7% YoY. Tangible book value also rose 9.2% to $35.35. The balance sheet strengthened significantly throughout the year alongside earnings recovery.
Stable. Up 6.3% YoY. Growth was driven by a >5% increase in premiums and contract charges. While growth is positive, it decelerated slightly from the 7.9% YoY growth seen in Q1.
Guidance
Beat. The company exceeded the upper end of its raised guidance range, driven by the P&C segment's outperformance.
Management stated top-line results set the stage for 'sustained, profitable growth in 2026'. Specific numerical guidance was referenced as being in the investor presentation but was not detailed in the press release text provided.
Key Questions
Q4 Earnings Bridge
Core earnings dropped 28% in Q4 despite revenue growth. How much of this was due to normalizing claim frequency versus one-time expenses, and does this run-rate signal a difficult start to 2026?
2026 Margin Sustainability
With the P&C combined ratio now sub-90%, is this level sustainable for 2026, or should investors expect normalization back toward the mid-90s as pricing tailwinds fade?
Investment Portfolio Health
Investment losses were a drag in Q4 ($5.6M). What is the outlook for the alternative asset portfolio and commercial mortgage loans in 2026 given the current rate environment?